Skip to main content

Closed

PHVS: Pharvaris N.V. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-72.8%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-1965.7×

Current ratio11.24×

Pharvaris N.V.

PHVSNASDAQ·USD·Closed

Pharvaris N.V.

PHVSNASDAQ·USD·Closed

$32.62

−3.72%

$32.62

−$1.26 (3.72%)

52W Range

77thpctl

Volume

1.18×avg

Mkt Cap

2.28BUSD

P/E

-10.0TTM

Div Yield

–ann

52W Range

77thpctl

Volume

1.18×avg

Market Cap

2.28BUSD

P/E Ratio

-10.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings